Filter posts

Strategic Venture Investing by Large Pharma: Is “Smart Money” Right for Your Company

The strategic venture arms of major biopharma companies like AbbVie, Amgen, Johnson & Johnson and …

Antibiotic Development Incentives May Be Tricky to Implement

A recently proposed broad suite of antibiotic development incentives has received strong support from industry …

Janet Napolitano and Jim Greenwood Talk Innovation, Homeland Security, and Politics at #BIO2016 Fir...

Janet Napolitano, President of the University of California, emphasized the need for research at every …

Achieving Healthcare Sustainability: Can we Move from “Value” to “Predictability”?

Drug costs are one of largest healthcare concerns across the American political spectrum. But drug …

The Value of Lifesaving Medicines: How Best To Define and Communicate The Innovations In Biopharmace...

One of BIO’s central goals is to promote the value of innovation in lifesaving medicines …

Californians Must Reject Scare Tactics, Stand Together In Support Of Innovation

This week, the BIO International Convention kicks off in San Francisco. As BIO’s President and …

BIO Start-Up Stadium: A Springboard to Partnering Success

An exciting BIO initiative, the BIO Start-Up Stadium, is back by popular demand at 2016 …

BIO 2016 Innovation Zone Company Snapshot: Montana Molecular

Now in its third year, the Innovation Zone at the BIO 2016 International Convention (San Francisco, June …

BIO 2016 Innovation Zone Company Snapshot: MicroDevice Engineering

Now in its third year, the Innovation Zone at the BIO 2016 International Convention (San …

BIO 2016 Innovation Zone Company Snapshot: Boston Mountain Biotech, LLC

Now in its third year, the Innovation Zone at the BIO 2016 International Convention (San …